← Leaderboards
Niroshana Anandasabapathy
Weill Medical Coll Of Cornell Univ
$9,090,896
Attributed
$9,090,896
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,090,896 · 6
By mechanism
R01$6,899,874 · 3
S10$816,944 · 1
K23$725,544 · 1
R56$648,534 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Xiaojing Ma$8,449,948
- Nicholas M Adams$84,454
- Mark Owyong$97,232
- Moustafa Gabr$7,041,425
- Sherry Xing Fan$54,538
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsImmunityImmuneT-LymphocyteSkinDendritic CellsLungIn VivoProgramsSurveysPeripheralBloodTissuesHomeostasisInflammationVaccinesMalignant NeoplasmsImmunologyImmune ToleranceAutoimmunityAntigensTumorProteinsGenes
Grant awards (22)
New mechanisms governing skin tissue residency memory T cells$671,214
R01 · FY2025 · AR · contact PI
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance$655,149
R01 · FY2025 · AR · contact PI
New mechanisms governing skin tissue residency memory T cells$757,027
R01 · FY2024 · AR · contact PI
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance$706,103
R01 · FY2024 · AR · contact PI
High-parametric flow cytometry cell sorter for human immunology studies.$816,944
S10 · FY2023 · OD · contact PI
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance$732,031
R01 · FY2023 · AR · contact PI
Interrogating unique DC adaptations to tissue to promote barrier immunity and tolerance$741,228
R01 · FY2022 · AR · contact PI
Peripheral immune surveillance and long-lived barrier immunity through T cell DC cross-talk$648,534
R56 · FY2021 · AR · contact PI
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells$455,723
R01 · FY2020 · AR · contact PI
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells$460,517
R01 · FY2019 · AR · contact PI
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells$471,480
R01 · FY2018 · AR · contact PI
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells$166,958
R01 · FY2018 · AR · contact PI
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells$342,415
R01 · FY2017 · AR · contact PI
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells$274,580
R01 · FY2017 · AR · contact PI
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells$55,852
R01 · FY2017 · AR · contact PI
Peripheral mechanisms of homeostasis and tolerance through skin dendritic cells$409,597
R01 · FY2016 · AR · contact PI
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells$178,200
K23 · FY2016 · AR · contact PI
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells$136,350
K23 · FY2015 · AR · contact PI
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells$136,350
K23 · FY2014 · AR · contact PI
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells$136,350
K23 · FY2013 · AR · contact PI
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells$82,444
K23 · FY2012 · AR · contact PI
The clinical use of Flt3L - an immune adjuvant to potentiate Dendritic Cells$55,850
K23 · FY2012 · AR · contact PI